Test of immunopotentialization in colposcopy--a clinical evaluation.
52 infertile women (age range 19-35 years) treated by Gynatren-immunopotentialization (three vaccinations every second week) were divided into two groups according to appearance of cervical intraepithelial neoplasia (CIN). 30 women had CIN cytologically diagnosed and proved by colposcopy (group II). Colposcopic examinations were performed on the first day of therapy (first vaccination), after two weeks (second vaccination) and after four weeks (the day of the third injection). Four weeks of the therapy resulted in normalization of cervical milieu (e.g., complete regression of infection in 68.2% of I group and 56% of II group) as well as in disappearance of CIN in 66% of cases and in remaining ones there was a 7-times decrease of CIN II. It was colposcopically stated that the process of statistical significant regression of inflammation as well as normalization of cervical pathology is less apparent in women with CIN. These findings confirmed our previous cytological observations.
Balajewicz
M
M
Institute for Obstetrics and Gynecology, Copernicus University School of Medicine, Cracow, Poland.
Dembowska
J
J
Klimek
R
R
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000328:Adult; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D003127:Colposcopy; D005260:Female; D006801:Humans; D002578:Uterine Cervical Dysplasia / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology
D000276:Adjuvants, Immunologic; D001428:Bacterial Vaccines; C039045:SolcoTrichovac